tiprankstipranks
Hansoh Pharmaceutical Group Company Limited (HK:3692)
:3692
Hong Kong Market
Want to see HK:3692 full AI Analyst Report?

Hansoh Pharmaceutical Group Company Limited (3692) Financial Statements

8 Followers

Hansoh Pharmaceutical Group Company Limited Financial Overview

Hansoh Pharmaceutical Group Company Limited's market cap is currently HK$203.76B. The company's EPS TTM is HK$0.93; its P/E ratio is 34.88; and it has a dividend yield of 0.97%. Hansoh Pharmaceutical Group Company Limited is scheduled to report earnings on March 29, 2026, and the estimated EPS forecast is HK$0.56. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 15.03B¥ 12.26B¥ 10.10B¥ 9.38B¥ 9.94B
Gross Profit¥ 13.51B¥ 11.16B¥ 9.07B¥ 8.51B¥ 9.06B
Operating Income¥ 5.42B¥ 4.03B¥ 2.84B¥ 2.67B¥ 2.90B
EBITDA¥ 5.77B¥ 4.28B¥ 4.20B¥ 2.93B¥ 3.08B
Net Income¥ 5.56B¥ 4.37B¥ 3.28B¥ 2.58B¥ 2.71B
Balance Sheet
Cash & Short-Term Investments¥ 31.58B¥ 23.39B¥ 24.86B¥ 21.63B¥ 18.94B
Total Assets¥ 39.92B¥ 31.66B¥ 33.04B¥ 30.00B¥ 27.16B
Total Debt¥ 105.14M¥ 117.89M¥ 4.30B¥ 4.38B¥ 3.83B
Net Debt¥ -3.31B¥ -22.50B¥ -18.13B¥ -13.24B¥ -10.87B
Total Liabilities¥ 4.54B¥ 2.98B¥ 7.24B¥ 7.35B¥ 7.13B
Stockholders' Equity¥ 35.38B¥ 28.68B¥ 25.79B¥ 22.65B¥ 20.03B
Cash Flow
Free Cash Flow¥ 6.25B¥ 3.64B¥ 2.90B¥ 2.47B¥ 2.12B
Operating Cash Flow¥ 6.74B¥ 3.86B¥ 3.12B¥ 2.74B¥ 2.58B
Investing Cash Flow¥ -7.15B¥ -1.39B¥ 1.07B¥ -5.94B¥ -2.26B
Financing Cash Flow¥ 1.55B¥ -6.07B¥ -753.70M¥ -818.14M¥ 3.42B
Currency in CNY

Hansoh Pharmaceutical Group Company Limited Earnings and Revenue History

Hansoh Pharmaceutical Group Company Limited Debt to Assets

Hansoh Pharmaceutical Group Company Limited Cash Flow

Hansoh Pharmaceutical Group Company Limited Forecast EPS vs Actual EPS